罗欣药业：聘任姜英为公司董事会秘书

Group 1 - The company announced the resignation of Mr. Han Fengsheng as the Secretary of the Board due to job relocation, while he will continue to serve as a director in the company's subsidiary, Shandong Luoxin Pharmaceutical Group Co., Ltd [1] - Ms. Jiang Ying has been appointed as the new Secretary of the Board following the nomination by the Chairman and approval by the Board of Directors [1] - As of the report date, the company's market capitalization is 5.3 billion yuan [1] Group 2 - For the first half of 2025, the company's revenue composition is as follows: pharmaceutical manufacturing accounts for 88.11%, pharmaceutical commerce for 10.1%, and other businesses for 1.79% [1]